Halozyme Therapeutics Inc. (HALO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Halozyme Therapeutics Inc...

NASDAQ: HALO · Real-Time Price · USD
74.93
1.53 (2.08%)
At close: Sep 05, 2025, 3:59 PM
74.87
-0.08%
After-hours: Sep 05, 2025, 07:31 PM EDT

Halozyme Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
115.85M 118.37M 234.19M 118.72M
Short-Term Investments
480.22M 217.63M 128.6M 622.2M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
80.6M 17.82M 26.8M 13.91M
Receivables
308.45M 234.21M 231.07M 90.97M
Inventory
141.86M 127.6M 100.12M 53.91M
Other Current Assets
38.95M 48.61M 45.02M n/a
Total Current Assets
1.09B 746.42M 739.01M 926.29M
Property-Plant & Equipment
75.03M 74.94M 75.57M 8.79M
Goodwill & Intangibles
818.65M 889.7M 955.7M n/a
Total Long-Term Assets
978.14M 986.85M 1.1B 178.14M
Total Assets
2.06B 1.73B 1.84B 1.1B
Account Payables
10.25M 11.82M 17.69M 1.54M
Deferred Revenue
n/a n/a 3.25M 1.75M
Short-Term Debt
n/a n/a 13.33M 89.42M
Other Current Liabilities
n/a n/a -3.25M n/a
Total Current Liabilities
139.1M 112.49M 130.79M 117.15M
Long-Term Debt
1.51B 1.5B 1.49B 787.25M
Other Long-Term Liabilities
54.76M 37.72M 45.91M 544K
Total Long-Term Liabilities
1.56B 1.54B 1.54B 790.33M
Total Liabilities
1.7B 1.65B 1.67B 907.48M
Total Debt
1.51B 1.5B 1.51B 876.67M
Common Stock
123K 127K 135K 138K
Retained Earnings
359.87M 90.55M 143.22M -58.91M
Comprehensive Income
3.83M -9.28M -922K -620K
Shareholders Equity
363.82M 83.81M 169.8M 196.95M
Total Investments
480.22M 217.63M 128.6M 622.2M